I agree that this site is using cookies. You can find further informations here.
X
Satwani, Prakash
185  results:
Search for persons X
?
1

Pathobiological signatures of dysbiotic lung injury in pedi..:

Zinter, Matt S. ; Dvorak, Christopher C. ; Mayday, Madeline Y....
Nature Medicine.  , 2024
Link: https://doi.org/10.1038/..
 
?
2

Establishing Costs for Commercial Chimeric Antigen Receptor..:

Satwani, Prakash ; Chao, Karen ; Lopez-Garcia, Maria...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S224-S225 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Risk Factors for Hematotoxicity Following Tisagenlecleucel ..:

McNerney, Kevin Owen ; Fabrizio, Vanessa A. ; Talleur, Aimee C....
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S219-S220 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Risk Factors Associated with Readmission Following Allogene..:

Garcia, Maria E Lopez ; Lieb, Kristin ; ZhenZhen, Jin...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S349 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Antiviral cellular therapy for enhancing T-cell reconstitut..:

Keller, Michael D. ; Hanley, Patrick J. ; Chi, Yueh-Yun...
Nature Communications.  15 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
6

Pediatric hematopoietic stem cell transplantation- Experien..:

Kamle, Akshay ; Patrikar, Smruti ; Chaudhary, Prachi..
Pediatric Hematology Oncology Journal.  8 (2023)  4 - p. S78 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Allogeneic Hematopoietic Cell Transplantation (AlloHCT) for..:

Chaudhary, Prachi ; Malpani, Preeti ; Chaube, Dharmanshu...
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S352-S353 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Tisagenlecleucel utilisation and outcomes across refractory..:

Barsan, Valentin ; Li, Yimei ; Prabhu, Snehit...
eClinicalMedicine.  65 (2023)  - p. 102268 , 2023
Link: https://doi.org/10.1016/..
 
?
9

High Disease Burden and Severe Neutropenia Predict HLH Toxi..:

McNerney, Kevin O. ; Lim, Stephanie Si ; Miller, Alexandra...
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S202-S203 , 2023
Link: https://doi.org/10.1016/..
 
?
10

HLH-like toxicities predict poor survival after the use of ..:

McNerney, Kevin O. ; Si Lim, Stephanie J. ; Ishikawa, Kyle...
Blood Advances.  7 (2023)  12 - p. 2758-2771 , 2023
Link: https://doi.org/10.1182/..
 
?
11

Higher doses of tisagenlecleucel are associated with improv..:

Stefanski, Heather E. ; Eaton, Anne ; Baggott, Christina...
Blood Advances.  7 (2023)  4 - p. 541-548 , 2023
Link: https://doi.org/10.1182/..
 
?
12

Mediport Use As an Acceptable Standard for CAR T Cell Infus..:

Eylon, Maya ; Baggott, Christina ; Prabhu, Snehit...
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S195-S196 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Mediport use as an acceptable standard for CAR T cell infus..:

Eylon, Maya ; Prabhu, Snehit ; John, Samuel...
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
14

CAR-Associated Hemophagocytic Lymphohistiocytosis (HLH) wit..:

McNerney, Kevin O. ; Lim, Stephanie Si ; Dreyzin, Alexandra...
Transplantation and Cellular Therapy.  28 (2022)  3 - p. S473-S475 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Real-world use of tisagenlecleucel in infant acute lymphobl..:

Moskop, Amy ; Pommert, Lauren ; Baggott, Christina...
Blood Advances.  6 (2022)  14 - p. 4251-4255 , 2022
Link: https://doi.org/10.1182/..
 
1-15